KAS
MRTX

Kemnay Advisory Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Kemnay Advisory Services’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,457
Closed -$759K – 114
2020
Q4 		$759K Buy
+3,457
New +$759K 0.1% 75